Bacterial vaginosis (BV) and complicated vulvovaginal candidiasis (VVC) are frequently occurring vaginal infections in postmenopausal women, caused by an imbalance in vaginal microflora. Postmenopausal women suffer from decreased ovarian hormones estrogen and progesterone. A normal, healthy vaginal microflora mainly comprises Lactobacillus species (spp.), which act beneficially as a bacterial barrier in the vagina, interfering with uropathogens. During premenopausal period, estrogen promotes vaginal colonization by lactobacilli that metabolizing glycogen and producing lactic acid, and maintains intravaginal health by lowering the intravaginal pH level. A lower vaginal pH inhibits uropathogen growth, preventing vaginal infections. Decreased estrogen secretion in postmenopausal women depletes lactobacilli and increases intravaginal pH, resulting in increased vaginal colonization by harmful microorganisms (e.g., Enterobacter, Escherichia coli, Candida, and Gardnerella). Probiotics positively effects on vaginal microflora composition by promoting the proliferation of beneficial microorganisms, alters the intravaginal microbiota composition, prevents vaginal infections in postmenopausal. Probiotics also reduce the symptoms of vaginal infections (e.g., vaginal discharge, odor, etc.), and are thus helpful for the treatment and prevention of BV and VVC. In this review article, we provide information on the intravaginal mechanism of postmenopausal vaginal infections, and describes the effectiveness of probiotics in the treatment and prevention of BV and VVC. 
Introduction
Demand for health functional foods are increasing as Korea is rapidly moving toward an aging society. 1 Especially, increase in elderly women due to prolonged lifespan in women promotes interest in postmenopausal health. However, because BV infection is asymptomatic and nonspecific in up to 50% of women, the reported prevalence of BV varies from 6% to 50%. 17 If Probiotics are defined as 'live microorganisms which when administered in adequate amounts confer a health benefit on the host' . 33 The beneficial effects of probiotics have been well-known include bowel disorders (e.g., intestinal health, lactose metabolism, diarrhea diseases), coronary heart disease, allergy, and cancer prevention. 34 cantly lower in the IG than in the CG, whereas G. vaginalis in the CG increased over time. BV symptoms were also decreased in the IG. 37 Studies have also shown the efficacy of probiotics combined with antibiotics in treating BV. Long-term antibiotic administration for BV was associated with adverse effects, including a high probability of BV recurrence due to antibiotic resistance derived from repeated exposure to antibiotics, whereas short-term administration combining antibiotics with probiotics decreased the number of harmful intravaginal microorganisms. This means that co-treatment with probiotics and antibiotics was more effective in BV treatment and recurrence prevention than was antibiotic administration alone. 38, 39 In the case of VVC, complicated VVC, which frequently occurs in postmenopausal women, requires a longer course of treatment than does uncomplicated VVC. Using antimicrobials in patients with complicated VVC is not as effective as it is in uncomplicated VVC due to antimicrobial resistance. 40 The Further studies on the action of probiotics on changes in the vaginal microbiota are required.
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